Core Viewpoint - The stock price of Brain Regeneration Technology has experienced a significant drop of 40% after a previous surge, raising concerns about the company's financial health and operational capabilities [4][5]. Company Overview - Brain Regeneration Technology is an early-stage biotechnology company focused on researching, developing, and commercializing traditional Chinese medicine for treating neurocognitive disorders, particularly ADHD and ASD [7]. - The company was founded in 2014 in Hong Kong and currently has only 12 employees [8]. Recent Developments - On June 20, 2025, the stock price fell to $38.01 per share, resulting in a total market capitalization of $18.8 billion (approximately 134.98 billion RMB) [4]. - Prior to the drop, the company announced that its next-generation neuro-regulation chip received FDA clinical trial approval and will collaborate with the Mayo Clinic to conduct research on Parkinson's disease, targeting a market of approximately 10 million patients [4][5]. Stock Performance - The stock price had previously surged over 4 times, with a closing increase of over 283% on June 16, 2025, and a year-to-date increase of nearly 500 times [4][5]. - The stock's volatility is highlighted by a maximum drawdown of 69.57% [5]. Financial Performance - Brain Regeneration Technology has not generated any revenue from product sales and has reported continuous losses in its financial statements [10]. - For the fiscal year ending June 30, 2024, the company reported total expenses of 473.67 million, resulting in a net loss of 430.18 million, which represents a 26.73% increase in losses compared to the previous year [11]. Ownership Structure - As of the first quarter of 2025, the largest shareholder is Yat-Gai Au, who holds an 86.24% stake in the company [12].

【导读】 脑再生科技大跌 40% 中国基金报记者 李智 此前狂飙的脑再生科技股价突然大跌。 脑再生科技大跌 40% 美东时间 6 月 20 日，脑再生科技盘中大幅下探。截至收盘，该股跌 40% ，股价报 38.01 美元 / 股，总市值为 188 亿美元（约合 1349.82 亿元人民币）。 | < W | | 脑再生 | | | | --- | --- | --- | --- | --- | | | RGC.O | | | | | 38.010 | 量 221.9万 | 股本 4.94亿 | 市盈 -4369 万得 | | | | | | 盘口 | | | -25.340 -40.00% 换 0.45% | | 市值1 188亿 | 市净 2287 | | | 盘后 35.250 -2.760 -7.26% | | | 美东 19:59 √ | | | 盘中 ▼ 五日 | | 周Ｋ | 草名 6 月K | | | 量加 | | | 均价:40.030 | | | 94.460 | | | 49.11% 卖一 35.250 | 2 | | | | | 或一 34.680 | 1 | | | | | 15:59 ...

Group 1 - As of June 20, 2025, there have been 32 new listings in the Hong Kong stock market, raising a total net amount of HKD 77.969 billion, significantly higher than the total of HKD 13.464 billion raised in the first half of 2024 [1] - The number of A-share companies listing in Hong Kong has increased, with 6 A+H share companies successfully listing this year, reflecting strong demand from investors for quality A-share listings [1] - The 6 A+H share companies had a strong debut in the Hong Kong market, with most experiencing double-digit percentage increases, and Chifeng Jilong Gold Mining Co. seeing a cumulative increase of 117.20% [1] Group 2 - The A-share company Sanhua Intelligent Controls is set to list in Hong Kong on June 23, 2025, with an issue price of HKD 22.53, aiming to raise HKD 0.811 billion for product development and global expansion [2] Group 3 - Traditional consumer stocks have underperformed, while new consumption stocks have thrived, with companies like Haitian Flavoring and Food Co. and Shubao International seeing significant stock price increases [3] - New consumption stocks such as milk tea brands have shown remarkable performance, with shares of Misha Group and Hu Shang Ayi increasing by 153.83% and 20.67% respectively since their listings [3] Group 4 - The trend of collectible toy stocks has also emerged, with Pop Mart International seeing a cumulative stock price increase of over 100% [4] - The toy company Blok has attracted significant interest, with its Hong Kong public offering being oversubscribed by 6,000 times [4] Group 5 - Five unprofitable biotech companies have listed in Hong Kong this year, with Mirxes and Brainstorm Aurora showing strong stock performance since their listings, with increases of 48.71% and 113.66% respectively [5][6] - The focus on "hard tech + medical" sectors has led to high valuations for these unprofitable biotech firms, despite their current losses [6] Group 6 - At least 10 more companies are expected to list in the remaining days of June, including traditional consumer stocks and unprofitable biotech firms, with their performance yet to be determined [7][8]

今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | PET铜箔 | 2.09 | 可燃冰 | -4.14 | | 光刻胶 | 1.45 | 脑机接口 | -3.34 | | BC电池 | 1.13 | 短剧游戏 | -3.07 | | 钙钛矿电池 | 1.06 | 智谱AI | -3.06 | | 航运概念 | 1.02 | 快手概念 | -2.99 | | 白酒概念 | 0.83 | MLOps概念 | -2.97 | | 兵装重组概念 | 0.80 | 华为盘古 | -2.80 | | 先进封装 | 0.79 | 财税数字化 | -2.79 | | 石墨电极 | 0.65 | 云办公 | -2.66 | | 低辐射玻璃(Low-E) | 0.64 | 小红书概念 | -2.53 | 资金面上看，今日脑机接口概念板块获主力资金净流出5.46亿元，其中，23股获主力资金净流出，7股 主力资金净流出超3000万元，净流出资金居首的是汉威科技，今日主力资金净流出1.33亿元，净流出资 金居前的还有创新医疗、汤姆猫、诚 ...

芯智达业务发展总监李园表示，侵入式脑机接口"北脑二号"将于年内完成微型无线全植入工程机的开 发，并有望于明年进入临床验证阶段。"北脑二号"是高性能侵入式智能脑机系统，由北京脑科学与类脑 研究所联合北京芯智达神经技术有限公司研发。(科创板日报) ...

沪指跌0.07%，深成指跌0.47%，创业板指跌0.84%。 6月20日，截至收盘，沪指跌0.07%，深成指跌0.47%，创业板指跌0.84%。 | | A股重要指数 | | 中文 | | --- | --- | --- | --- | | 名称 | 最新 | 涨跌 | 涨幅 | | 上证指数 | 3359.90 | -2.21 | -0.07% | | 深证成指 | 10005.03 | -46.94 | -0.47% | | 北证50 | 1347.46 | -18.33 | -1.34% | | 创业板指 | 2009.89 | -16.93 | -0.84% | | 科创综指 | 1160.80 | -8.03 | -0.69% | 沪深两市全天成交额1.07万亿。 个股跌多涨少，全市场超3600只个股下跌。 | 27 全A 1 231 跌 364 4 1 | | --- | | F 200 | 盘面上看，白酒、港口航运、银行、电池等板块涨幅居前，油气、脑机接口、短剧、游戏等板块跌幅居 前。 具体来看，白酒板块表现强势，皇台酒业涨停，迎驾贡酒涨逾7%，金种子酒涨5%，泸州老窖、水井坊 等跟涨。 港口航 ...

Group 1 - The Hong Kong stock market showed a strong performance with the Hang Seng Index rising by 1.15% to 23,504.59 points and the Tech Index increasing by 0.71% to 5,124.36 points [1] - The insurance and banking sectors led the market rally, with notable gains in semiconductor stocks and active trading in Apple-related stocks [1] - Individual stock performances included a significant rise in Feifan Lingyue (00933.HK) by 22%, Li Ning (02331.HK) by 6.8%, and China Life (02628.HK) by 4.3% [1] Group 2 - Other notable gainers included Sunny Optical Technology (02382.HK) up by 3.9%, Industrial and Commercial Bank of China (01398.HK) and Ping An Insurance (02318.HK) both rising by 3.15%, and Huahong Semiconductor (01347.HK) increasing by 2.8% [1] - Conversely, some stocks experienced declines, such as Pop Mart (09992.HK) down by 5.2%, Nanjing Panda Electronics (00553.HK) down by 7.2%, and Jixing New Energy (03395.HK) dropping over 14% [1]

A股三大股指早盘走势分化，截至中午收盘，沪指涨0.08%，深证成指跌0.19%，创业板指跌0.56%；沪 深两市半日成交额6863亿，较上个交易日缩量1196亿。全市场超3200只个股飘绿。盘面上，白酒股领 涨，皇台酒业涨停，迎驾贡酒、金种子酒、古井贡酒跟涨。光刻胶板块活跃，强力新材、芯原股份、肯 特催化涨停。BC电池版涨幅居前，正业科技、赛伍技术、协鑫集成涨停。银行股震荡上行，杭州银 行、浦发银行、交通银行等多只股票创历史新高。贵金属板块领跌，西部黄金跌近7%。IP经济概念震 荡调整，元隆雅图逼近跌停，中文在线跌近8%。脑机接口概念、游戏传媒回调。新股N新恒汇涨 268.7%，N华之杰涨216.7%。 A股午评：三大股指走势分化 白酒股领涨 ...

午评：创业板指半日跌超0.56% 白酒、航运股逆势走强 智通财经6月20日电，市场早盘震荡回落，三大指数涨跌不一。沪深两市半日成交额6710亿，较上个交 易日缩量1167亿。盘面上热点较为杂乱，个股跌多涨少，全市场超3200只个股下跌。从板块来看，白酒 股展开反弹，皇台酒业涨停。港口航运股震荡走强，宁波海运涨停。固态电池概念股一度冲高，海科新 源20CM涨停。下跌方面，脑机接口概念股展开调整，爱朋医疗跌超10%。板块方面，白酒、航运、光 伏、固态电池等板块涨幅居前，脑机接口、短剧、游戏、油气等板块跌幅居前。截至收盘，沪指涨 0.08%，深成指跌0.19%，创业板指跌0.56%。 ...

今日导读 1.今日收盘后，富时罗素对富时中国50指数、富时中国A50指数、富时中国A150指数、富时 中国A200指数及富时中国A400指数的季度审核变更生效。 2. 6月19日，阿里云宣布将于本月底在韩国启用第二座数据中心，来满足生成式AI快速发展 带来的需求增长。 3.6月19日，据多方信源确认，宇树科技已经完成了始于去年底C轮融资的交割，由移动旗下 基金、腾讯、锦秋、阿里、蚂蚁、吉利资本共同领投，绝大部分老股东参与了跟投。 宏观消息 4、中国物流与采购联合会于19日公布《中国公共采购发展报告（2024）》。根据报告，2024年全国 公共采购总额较上一年有所下降，结构分化明显，国企采购发挥压舱石的作用。 5、今日收盘后，富时罗素对富时中国50指数、富时中国A50指数、富时中国A150指数、富时中国 A200指数及富时中国A400指数的季度审核变更生效。富时中国A50指数此次将江苏银行纳入，剔除长 城汽车，同时将百济神州、伊利股份、上汽集团、赛力斯、汇川技术等纳入备选名单。富时中国A50 指数由上海和深圳证券交易所市场中总市值最大的50只股票组成，反映A股市场中最具影响力的前50 大上市公司股票的表现，不少 ...